BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

790 related articles for article (PubMed ID: 19789351)

  • 1. Oncogenesis caused by loss of the SNF5 tumor suppressor is dependent on activity of BRG1, the ATPase of the SWI/SNF chromatin remodeling complex.
    Wang X; Sansam CG; Thom CS; Metzger D; Evans JA; Nguyen PT; Roberts CW
    Cancer Res; 2009 Oct; 69(20):8094-101. PubMed ID: 19789351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SRG3 interacts directly with the major components of the SWI/SNF chromatin remodeling complex and protects them from proteasomal degradation.
    Sohn DH; Lee KY; Lee C; Oh J; Chung H; Jeon SH; Seong RH
    J Biol Chem; 2007 Apr; 282(14):10614-24. PubMed ID: 17255092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of Snf5 Induces Formation of an Aberrant SWI/SNF Complex.
    Sen P; Luo J; Hada A; Hailu SG; Dechassa ML; Persinger J; Brahma S; Paul S; Ranish J; Bartholomew B
    Cell Rep; 2017 Feb; 18(9):2135-2147. PubMed ID: 28249160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SNF5/INI1 deficiency redefines chromatin remodeling complex composition during tumor development.
    Wei D; Goldfarb D; Song S; Cannon C; Yan F; Sakellariou-Thompson D; Emanuele M; Major MB; Weissman BE; Kuwahara Y
    Mol Cancer Res; 2014 Nov; 12(11):1574-85. PubMed ID: 25009291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation.
    Wilson BG; Helming KC; Wang X; Kim Y; Vazquez F; Jagani Z; Hahn WC; Roberts CW
    Mol Cell Biol; 2014 Mar; 34(6):1136-44. PubMed ID: 24421395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma.
    Schallenberg S; Bork J; Essakly A; Alakus H; Buettner R; Hillmer AM; Bruns C; Schroeder W; Zander T; Loeser H; Gebauer F; Quaas A
    BMC Cancer; 2020 Jan; 20(1):12. PubMed ID: 31906887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic inactivation of the tumor suppressor BIN1 drives proliferation of SNF5-deficient tumors.
    McKenna ES; Tamayo P; Cho YJ; Tillman EJ; Mora-Blanco EL; Sansam CG; Koellhoffer EC; Pomeroy SL; Roberts CW
    Cell Cycle; 2012 May; 11(10):1956-65. PubMed ID: 22544318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammalian chromatin remodeling complex SWI/SNF is essential for enhanced expression of the albumin gene during liver development.
    Inayoshi Y; Miyake K; Machida Y; Kaneoka H; Terajima M; Dohda T; Takahashi M; Iijima S
    J Biochem; 2006 Feb; 139(2):177-88. PubMed ID: 16452305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of the chromatin-remodeling factor BRG1/SMARCA4 in human cancer.
    Medina PP; Sanchez-Cespedes M
    Epigenetics; 2008; 3(2):64-8. PubMed ID: 18437052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple interactions of the oncoprotein transcription factor MYC with the SWI/SNF chromatin remodeler.
    Woodley CM; Romer AS; Wang J; Guarnaccia AD; Elion DL; Maxwell JN; Guerrazzi K; McCann TS; Popay TM; Matlock BK; Flaherty DK; Lorey SL; Liu Q; Tansey WP; Weissmiller AM
    Oncogene; 2021 May; 40(20):3593-3609. PubMed ID: 33931740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Swi/Snf chromatin remodeling/tumor suppressor complex establishes nucleosome occupancy at target promoters.
    Tolstorukov MY; Sansam CG; Lu P; Koellhoffer EC; Helming KC; Alver BH; Tillman EJ; Evans JA; Wilson BG; Park PJ; Roberts CW
    Proc Natl Acad Sci U S A; 2013 Jun; 110(25):10165-70. PubMed ID: 23723349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneous SWI/SNF chromatin remodeling complexes promote expression of microphthalmia-associated transcription factor target genes in melanoma.
    Keenen B; Qi H; Saladi SV; Yeung M; de la Serna IL
    Oncogene; 2010 Jan; 29(1):81-92. PubMed ID: 19784067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cdx2 Regulates Gene Expression through Recruitment of Brg1-associated Switch-Sucrose Non-fermentable (SWI-SNF) Chromatin Remodeling Activity.
    Nguyen TT; Savory JGA; Brooke-Bisschop T; Ringuette R; Foley T; Hess BL; Mulatz KJ; Trinkle-Mulcahy L; Lohnes D
    J Biol Chem; 2017 Feb; 292(8):3389-3399. PubMed ID: 28082674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BAFfling pathologies: Alterations of BAF complexes in cancer.
    Arnaud O; Le Loarer F; Tirode F
    Cancer Lett; 2018 Apr; 419():266-279. PubMed ID: 29374542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SWI/SNF chromatin remodeling subunit BRG1 is a critical regulator of p53 necessary for proliferation of malignant cells.
    Naidu SR; Love IM; Imbalzano AN; Grossman SR; Androphy EJ
    Oncogene; 2009 Jul; 28(27):2492-501. PubMed ID: 19448667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of SWI/SNF chromatin remodeling factor subunits modulates cisplatin cytotoxicity.
    Kothandapani A; Gopalakrishnan K; Kahali B; Reisman D; Patrick SM
    Exp Cell Res; 2012 Oct; 318(16):1973-86. PubMed ID: 22721696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Casein kinase 2-mediated phosphorylation of Brahma-related gene 1 controls myoblast proliferation and contributes to SWI/SNF complex composition.
    Padilla-Benavides T; Nasipak BT; Paskavitz AL; Haokip DT; Schnabl JM; Nickerson JA; Imbalzano AN
    J Biol Chem; 2017 Nov; 292(45):18592-18607. PubMed ID: 28939766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional activation by pRB and its coordination with SWI/SNF recruitment.
    Flowers S; Beck GR; Moran E
    Cancer Res; 2010 Nov; 70(21):8282-7. PubMed ID: 20851996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular matrix-regulated gene expression requires cooperation of SWI/SNF and transcription factors.
    Xu R; Spencer VA; Bissell MJ
    J Biol Chem; 2007 May; 282(20):14992-9. PubMed ID: 17387179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MITF-independent pro-survival role of BRG1-containing SWI/SNF complex in melanoma cells.
    Ondrušová L; Vachtenheim J; Réda J; Záková P; Benková K
    PLoS One; 2013; 8(1):e54110. PubMed ID: 23349796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.